Selective Serotonin Reuptake Inhibitors

Antidepressants are medicines used to help people who have depression. Selective Serotonin Reuptake Inhibitors (SSRIs) are members of a group of antidepressants that includes drugs such as citalopram (brand name of Celexa), fluoxetine (brand name of Prozac), paroxetine (brand name of Paxil) and sertraline (brand name of Zoloft).

Follow the links below to find information about selective serotonin reuptake inhibitors (SSRIs).

Reviewed April 2009

 

Printer friendly page

22 Resources Found
Results 1 to 20 displayed.
1    2   

Title:   Selective serotonin reuptake inhibitors (SSRIs) for depression
Publisher:   myDr
Description:   Selective serotonin reuptake inhibitors (SSRIs) are antidepressant medicines that relieve depression by making more of the brain chemical serotonin available to activate nerve cells.
Date:   Mar 2009

Title:   Pharmacotherapy and psychotherapy for body dysmorphic disorder
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Body dysmorphic disorder (BDD) is a condition characterised by a distressing and disabling preoccupation with an imagined or slight defect in appearance. This causes people with this disorder either significant distress or disrupts their daily functioni...
Date:   Jan 2009

Title:   Sertraline versus other antidepressive agents for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Depression is the fourth leading cause of disease burden worldwide and is expected to show a rising trend over the next 20 years. Depression is associated with a marked personal, social and economic morbidity, loss of functioning and productivity, and c...
Date:   Jul 2008

Title:   Escitalopram versus other antidepressive agents for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs remain the mainstay of treatment. During the last 20 years, selective serotonin reuptake inhibitors (SSRIs) have progressively become ...
Date:   Jun 2008

Title:   Fact sheet for GPs - antidepressants for the treatment of depression in children and adolescents
Publisher:   beyondblue
Description:   Depression is a common condition that affects people of all ages, including children and young people. It is also a serious condition, associated with significant impairment, disability and death from suicide. Effective treatments are available and prompt intervention is important.
Date:   Jan 2008

Title:   Fact sheet for young people - antidepressants for the treatment of depression in children and adolescents
Publisher:   beyondblue
Description:   While antidepressant medicines have been used to treatyoung people under 18 years with more severe depression, there is much debate among doctors as to the benefits of these medicines with young people. One of the main reasons why doctors have found it difficult to give clear recommendations is because of the lack of research on the impact of antidepressants with young people.
Date:   Jan 2008

Title:   Fact sheet for parents and carers: antidepressants for the treatment of depression in children and adolescents
Publisher:   beyondblue
Description:   This fact sheet has been prepared for parents and other carers. It provides information about the use of antidepressant medications for the treatment of depression in children and young people.
Date:   Jan 2008

Title:   Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Obsessive compulsive disorder (OCD) is a common and disabling disorder, which frequently follows a chronic course. It is characterised by intrusive thoughts of imagined harm, which are difficult to dispel, and ritualistic behaviour such as repetitive wa...
Date:   Nov 2007

Title:   Antidepressants in pregnancy and breastfeeding
Publisher:   Australian Prescriber
Description:   Clinicians must consider the risk of damage from the medications and the effects of the illness itself on both the mother and the baby.
Date:   Oct 2007

Title:   Amitriptyline for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Amitriptyline still has a place in the pharmacological management of depressive episodes. The findings of this systematic review showed that in comparison with control agents, amitriptyline was slightly more effective, but the burden of side-effects was...
Date:   May 2007

Title:   Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Depressive disorders are common in young people and have significant negative impacts. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for the treatment of depressive disorder in children and adolescents. The review of 12 trials ...
Date:   Mar 2007

Title:   Antidepressants for patients with tinnitus
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tinnitus is described as the perception of sound or noise in the absence of real acoustic stimulation, and is frequently associated with depression or depressive symptoms. Five studies matched the inclusion criteria for this review. Four evaluated three...
Date:   Aug 2006

Title:   Antidepressants for depressed elderly
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review compared the efficacy, withdrawal rates and side effects of different antidepressant classes in the treatment of depression in older people. Thirty-two studies provided data for the review. Our main findings indicate that tricyclic antidepre...
Date:   Feb 2006

Title:   Children, serotonin and suicide
Publisher:   Australian Prescriber
Description:   Controlled trials show that psychosocial treatments are effective in mild to moderate paediatric depression. However effectiveness in severe depression is questionable. This raises the question of drug treatment
Date:   Oct 2005

Title:   Information for health professionals concerning use of SSRI antidepressants in pregnant women
Publisher:   Australian Government Department of Health and Ageing
Description:   New information has recently become available that suggests pregnant women who take SSRI antidepressant medicines in early pregnancy may have an increased risk of giving birth to an infant with a heart problem. This association appears to be strongest for the SSRI medicine, paroxetine.
Date:   Sep 2005

Title:   General information concerning use of SSRI antidepressants in pregnant women
Publisher:   Australian Government Department of Health and Ageing
Description:   New information has recently become available that suggests pregnant women who take SSRI antidepressant medicines in early pregnancy may have an increased risk of giving birth to an infant with a heart problem. This association appears to be strongest for the SSRI medicine, paroxetine.
Date:   Sep 2005

Title:   Advice for women taking paroxetine intending to become pregnant or in early pregnancy
Publisher:   Australian Government Department of Health and Ageing
Description:   There is some information to suggest that use of the medicine paroxetine in early pregnancy (first 13 weeks) may be associated with an increased risk of some congenital malformations in babies. It is not proven that this does occur.
Date:   Sep 2005

Title:   Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Migraine and tension-type headaches are common and can interfere significantly with social functioning, daily activities, and work. People with very frequent or severe headaches may benefit from preventive drug therapy. Selective serotonin re-uptake inh...
Date:   Mar 2005

Title:   Use of SSRI antidepressants in children and adolescents
Publisher:   Australian Government Department of Health and Ageing
Description:   The Australian Adverse Drug Reactions Advisory Committee (ADRAC) has considered the safety and efficacy of the Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in children and adolescents.
Date:   Mar 2004

Title:   Selective serotonin reuptake inhibitors for premenstrual syndrome
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Premenstrual syndrome (PMS) is a common cause of mood changes, stomach discomfort, pain, headaches, anxiety and irritability in women. These symptoms are relieved by the onset of, or during, menstruation. PMS can severely disrupt the lives of some wome...
Date:   Feb 2002
Results 1 to 20 displayed.
1    2